Derma Sciences, Inc (DSCI)

[xxxxtrader]

Derma Sciences to Hold Conference Call to Discuss Results from Phase 2 DSC127 Trial in Diabetic Foot Ulcers February 3

Press Release Source: Derma Sciences, Inc. On Wednesday February 2, 2011, 4:05 pm EST

PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq:DSCI - News), a medical device and pharmaceutical company focused on advanced wound care, will issue a news release announcing top-line efficacy results from its Phase 2 trial with DSC127 in diabetic foot ulcers at 7:00 a.m. Eastern time Thursday, February 3 and will hold a conference call to discuss those results at 10:00 a.m. Eastern time that same day.



To participate in the conference call, from the U.S. please dial [phone] and from outside the U.S. please dial [phone]. All listeners should provide passcode 41467730. Individuals interested in listening to the live conference call via the Internet may do so by logging onto the Company’s website, www.dermasciences.com.



Following the completion of the conference call, a replay will be available through February 10, 2011, and can be accessed by dialing [phone] from the U.S. or [phone] from outside of the U.S. All listeners should provide passcode 41467730. The webcast will also be available on the Company’s website for 30 days.